-
1
-
-
80053989452
-
Intraoperative tumorspecific fluorescence imaging in ovarian cancer by folate receptor-α targeting: First in-human results
-
G. M. Van Dam, G. Themelis, L. M. Crane, N. J. Harlaar, R. G. Pleijhuis, W. Kelder, A. Sarantopoulos, J. S. De Jong, H. J. Arts, A. G. Van Der Zee, J. Bart, P. S. Low, V. Ntziachristos, Intraoperative tumorspecific fluorescence imaging in ovarian cancer by folate receptor-α targeting: First in-human results. Nat. Med. 17, 1315-1319 (2011).
-
(2011)
Nat. Med.
, vol.17
, pp. 1315-1319
-
-
Van Dam, G.M.1
Themelis, G.2
Crane, L.M.3
Harlaar, N.J.4
Pleijhuis, R.G.5
Kelder, W.6
Sarantopoulos, A.7
De Jong, J.S.8
Arts, H.J.9
Van Der Zee, A.G.10
Bart, J.11
Low, P.S.12
Ntziachristos, V.13
-
2
-
-
84883192924
-
Fluorescence-guided surgery with live molecular navigation-A new cutting edge
-
Q. T. Nguyen, R. Y. Tsien, Fluorescence-guided surgery with live molecular navigation-A new cutting edge. Nat. Rev. Cancer 13, 653-662 (2013).
-
(2013)
Nat. Rev. Cancer
, vol.13
, pp. 653-662
-
-
Nguyen, Q.T.1
Tsien, R.Y.2
-
3
-
-
84892805731
-
Cancer statistics, 2014
-
R. Siegel, J. Ma, Z. Zou, A. Jemal, Cancer statistics, 2014. CA Cancer J. Clin. 64, 9-29 (2014).
-
(2014)
CA Cancer J. Clin.
, vol.64
, pp. 9-29
-
-
Siegel, R.1
Ma, J.2
Zou, Z.3
Jemal, A.4
-
4
-
-
76149083899
-
Update on the management of non-muscle invasive bladder cancer
-
S. Aldousari, W. Kassouf, Update on the management of non-muscle invasive bladder cancer. Can. Urol. Assoc. J. 4, 56-64 (2010).
-
(2010)
Can. Urol. Assoc. J.
, vol.4
, pp. 56-64
-
-
Aldousari, S.1
Kassouf, W.2
-
5
-
-
32944465832
-
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
-
discussion 475-477
-
R. J. Sylvester, A. P. Van Der Meijden, W. Oosterlinck, J. A. Witjes, C. Bouffioux, L. Denis, D. W. Newling, K. Kurth, Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 49, 466-475; discussion 475-477 (2006).
-
(2006)
Eur. Urol.
, vol.49
, pp. 466-475
-
-
Sylvester, R.J.1
Van Der Meijden, A.P.2
Oosterlinck, W.3
Witjes, J.A.4
Bouffioux, C.5
Denis, L.6
Newling, D.W.7
Kurth, K.8
-
6
-
-
30044441045
-
Bladder cancer: Epidemiology, staging and grading, and diagnosis
-
Z. Kirkali, T. Chan, M. Manoharan, F. Algaba, C. Busch, L. Cheng, L. Kiemeney, M. Kriegmair, R. Montironi, W. M. Murphy, I. A. Sesterhenn, M. Tachibana, J. Weider, Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urology 66, 4-34 (2005).
-
(2005)
Urology
, vol.66
, pp. 4-34
-
-
Kirkali, Z.1
Chan, T.2
Manoharan, M.3
Algaba, F.4
Busch, C.5
Cheng, L.6
Kiemeney, L.7
Kriegmair, M.8
Montironi, R.9
Murphy, W.M.10
Sesterhenn, I.A.11
Tachibana, M.12
Weider, J.13
-
7
-
-
84876482422
-
Action on Bladder Cancer, Current perspectives in bladder cancer management
-
T. R. Griffiths; Action on Bladder Cancer, Current perspectives in bladder cancer management. Int. J. Clin. Pract. 67, 435-448 (2013).
-
(2013)
Int. J. Clin. Pract.
, vol.67
, pp. 435-448
-
-
Griffiths, T.R.1
-
8
-
-
84863727612
-
New optical imaging technologies for bladder cancer: Considerations and perspectives
-
J. J. Liu, M. J. Droller, J. C. Liao, New optical imaging technologies for bladder cancer: Considerations and perspectives. J. Urol. 188, 361-368 (2012).
-
(2012)
J. Urol.
, vol.188
, pp. 361-368
-
-
Liu, J.J.1
Droller, M.J.2
Liao, J.C.3
-
9
-
-
77957834145
-
Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer
-
A. Stenzl, M. Burger, Y. Fradet, L. A. Mynderse, M. S. Soloway, J. A. Witjes, M. Kriegmair, A. Karl, Y. Shen, H. B. Grossman, Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J. Urol. 184, 1907-1913 (2010).
-
(2010)
J. Urol.
, vol.184
, pp. 1907-1913
-
-
Stenzl, A.1
Burger, M.2
Fradet, Y.3
Mynderse, L.A.4
Soloway, M.S.5
Witjes, J.A.6
Kriegmair, M.7
Karl, A.8
Shen, Y.9
Grossman, H.B.10
-
10
-
-
60349122808
-
Fibered confocal microscopy of bladder tumors: An ex vivo study
-
G. A. Sonn, K. E. Mach, K. Jensen, P. L. Hsiung, S. N. Jones, C. H. Contag, T. D. Wang, J. C. Liao, Fibered confocal microscopy of bladder tumors: An ex vivo study. J. Endourol. 23, 197-201 (2009).
-
(2009)
J. Endourol.
, vol.23
, pp. 197-201
-
-
Sonn, G.A.1
Mach, K.E.2
Jensen, K.3
Hsiung, P.L.4
Jones, S.N.5
Contag, C.H.6
Wang, T.D.7
Liao, J.C.8
-
11
-
-
69749100062
-
Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy
-
G. A. Sonn, S. N. Jones, T. V. Tarin, C. B. Du, K. E. Mach, K. C. Jensen, J. C. Liao, Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy. J. Urol. 182, 1299-1305 (2009).
-
(2009)
J. Urol.
, vol.182
, pp. 1299-1305
-
-
Sonn, G.A.1
Jones, S.N.2
Tarin, T.V.3
Du, C.B.4
Mach, K.E.5
Jensen, K.C.6
Liao, J.C.7
-
12
-
-
79959745868
-
Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy
-
K. Wu, J. J. Liu, W. Adams, G. A. Sonn, K. E. Mach, Y. Pan, A. H. Beck, K. C. Jensen, J. C. Liao, Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy. Urology 78, 225-231 (2011).
-
(2011)
Urology
, vol.78
, pp. 225-231
-
-
Wu, K.1
Liu, J.J.2
Adams, W.3
Sonn, G.A.4
Mach, K.E.5
Pan, Y.6
Beck, A.H.7
Jensen, K.C.8
Liao, J.C.9
-
13
-
-
84860174226
-
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
-
S. B. Willingham, J. P. Volkmer, A. J. Gentles, D. Sahoo, P. Dalerba, S. S. Mitra, J. Wang, H. Contreras-Trujillo, R. Martin, J. D. Cohen, P. Lovelace, F. A. Scheeren, M. P. Chao, K. Weiskopf, C. Tang, A. K. Volkmer, T. J. Naik, T. A. Storm, A. R. Mosley, B. Edris, S. M. Schmid, C. K. Sun, M. S. Chua, O. Murillo, P. Rajendran, A. C. Cha, R. K. Chin, D. Kim, M. Adorno, T. Raveh, D. Tseng, S. Jaiswal, P. Ø. Enger, G. K. Steinberg, G. Li, S. K. So, R. Majeti, G. R. Harsh, M. Van De Rijn, N. N. Teng, J. B. Sunwoo, A. A. Alizadeh, M. F. Clarke, I. L. Weissman, The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc. Natl. Acad. Sci. U. S. A. 109, 6662-6667 (2012).
-
(2012)
Proc. Natl. Acad. Sci. U. S. A.
, vol.109
, pp. 6662-6667
-
-
Willingham, S.B.1
Volkmer, J.P.2
Gentles, A.J.3
Sahoo, D.4
Dalerba, P.5
Mitra, S.S.6
Wang, J.7
Contreras-Trujillo, H.8
Martin, R.9
Cohen, J.D.10
Lovelace, P.11
Scheeren, F.A.12
Chao, M.P.13
Weiskopf, K.14
Tang, C.15
Volkmer, A.K.16
Naik, T.J.17
Storm, T.A.18
Mosley, A.R.19
Edris, B.20
Schmid, S.M.21
Sun, C.K.22
Chua, M.S.23
Murillo, O.24
Rajendran, P.25
Cha, A.C.26
Chin, R.K.27
Kim, D.28
Adorno, M.29
Raveh, T.30
Tseng, D.31
Jaiswal, S.32
Enger P.Ø.33
Steinberg, G.K.34
Li, G.35
So, S.K.36
Majeti, R.37
Harsh, G.R.38
Van De Rijn, M.39
Teng, N.N.40
Sunwoo, J.B.41
Alizadeh, A.A.42
Clarke, M.F.43
Weissman, I.L.44
more..
-
14
-
-
69549114870
-
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
-
K. S. Chan, I. Espinosa, M. Chao, D. Wong, L. Ailles, M. Diehn, H. Gill, J. Presti Jr., H. Y. Chang, M. Van De Rijn, L. Shortliffe, I. L. Weissman, Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl. Acad. Sci. U. S. A. 106, 14016-14021 (2009).
-
(2009)
Proc. Natl. Acad. Sci. U. S. A.
, vol.106
, pp. 14016-14021
-
-
Chan, K.S.1
Espinosa, I.2
Chao, M.3
Wong, D.4
Ailles, L.5
Diehn, M.6
Gill, H.7
Presti, J.8
Chang, H.Y.9
Van De Rijn, M.10
Shortliffe, L.11
Weissman, I.L.12
-
15
-
-
34547120244
-
Extracting binary signals from microarray time-course data
-
D. Sahoo, D. L. Dill, R. Tibshirani, S. K. Plevritis, Extracting binary signals from microarray time-course data. Nucleic Acids Res. 35, 3705-3712 (2007).
-
(2007)
Nucleic Acids Res.
, vol.35
, pp. 3705-3712
-
-
Sahoo, D.1
Dill, D.L.2
Tibshirani, R.3
Plevritis, S.K.4
-
16
-
-
33644867290
-
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
-
M. Sanchez-Carbayo, N. D. Socci, J. Lozano, F. Saint, C. Cordon-Cardo, Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J. Clin. Oncol. 24, 778-789 (2006).
-
(2006)
J. Clin. Oncol.
, vol.24
, pp. 778-789
-
-
Sanchez-Carbayo, M.1
Socci, N.D.2
Lozano, J.3
Saint, F.4
Cordon-Cardo, C.5
-
17
-
-
57249116912
-
Boolean implication networks derived from large scale, whole genome microarray datasets
-
D. Sahoo, D. L. Dill, A. J. Gentles, R. Tibshirani, S. K. Plevritis, Boolean implication networks derived from large scale, whole genome microarray datasets. Genome Biol. 9, R157 (2008).
-
(2008)
Genome Biol.
, vol.9
, pp. R157
-
-
Sahoo, D.1
Dill, D.L.2
Gentles, A.J.3
Tibshirani, R.4
Plevritis, S.K.5
-
18
-
-
77953853118
-
Molecular pathways of urothelial development and bladder tumorigenesis
-
M. Castillo-Martin, J. Domingo-Domenech, O. Karni-Schmidt, T. Matos, C. Cordon-Cardo, Molecular pathways of urothelial development and bladder tumorigenesis. Urol. Oncol. 28, 401-408 (2010).
-
(2010)
Urol. Oncol.
, vol.28
, pp. 401-408
-
-
Castillo-Martin, M.1
Domingo-Domenech, J.2
Karni-Schmidt, O.3
Matos, T.4
Cordon-Cardo, C.5
-
19
-
-
34547612220
-
Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: A success story with room for improvement
-
S. Brandau, H. Suttmann, Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: A success story with room for improvement. Biomed. Pharmacother. 61, 299-305 (2007).
-
(2007)
Biomed. Pharmacother.
, vol.61
, pp. 299-305
-
-
Brandau, S.1
Suttmann, H.2
-
20
-
-
41849147483
-
Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy
-
P. L. Hsiung, J. Hardy, S. Friedland, R. Soetikno, C. B. Du, A. P. Wu, P. Sahbaie, J. M. Crawford, A. W. Lowe, C. H. Contag, T. D. Wang, Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat. Med. 14, 454-458 (2008).
-
(2008)
Nat. Med.
, vol.14
, pp. 454-458
-
-
Hsiung, P.L.1
Hardy, J.2
Friedland, S.3
Soetikno, R.4
Du, C.B.5
Wu, A.P.6
Sahbaie, P.7
Crawford, J.M.8
Lowe, A.W.9
Contag, C.H.10
Wang, T.D.11
-
21
-
-
84878266233
-
Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: First-in-human results
-
M. B. Sturm, B. P. Joshi, S. Lu, C. Piraka, S. Khondee, B. J. Elmunzer, R. S. Kwon, D. G. Beer, H. D. Appelman, D. K. Turgeon, T. D. Wang, Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: First-in-human results. Sci. Transl. Med. 5, 184ra61 (2013).
-
(2013)
Sci. Transl. Med.
, vol.5
, pp. 184ra61
-
-
Sturm, M.B.1
Joshi, B.P.2
Lu, S.3
Piraka, C.4
Khondee, S.5
Elmunzer, B.J.6
Kwon, R.S.7
Beer, D.G.8
Appelman, H.D.9
Turgeon, D.K.10
Wang, T.D.11
-
22
-
-
67149084303
-
Histological variants of urothelial carcinoma: Diagnostic, therapeutic and prognostic implications
-
M. B. Amin, Histological variants of urothelial carcinoma: Diagnostic, therapeutic and prognostic implications. Mod. Pathol. 22, S96-S118 (2009).
-
(2009)
Mod. Pathol.
, vol.22
, pp. S96-S118
-
-
Amin, M.B.1
-
23
-
-
84862154878
-
Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy
-
H. B. Grossman, A. Stenzl, Y. Fradet, L. A. Mynderse, M. Kriegmair, J. A. Witjes, M. S. Soloway, A. Karl, M. Burger, Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J. Urol. 188, 58-62 (2012).
-
(2012)
J. Urol.
, vol.188
, pp. 58-62
-
-
Grossman, H.B.1
Stenzl, A.2
Fradet, Y.3
Mynderse, L.A.4
Kriegmair, M.5
Witjes, J.A.6
Soloway, M.S.7
Karl, A.8
Burger, M.9
-
24
-
-
84885429377
-
Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: A meta-analysis of detection and recurrence based on raw data
-
M. Burger, H. B. Grossman, M. Droller, J. Schmidbauer, G. Hermann, O. Drəgoescu, E. Ray, Y. Fradet, A. Karl, J. P. Burgués, J. A. Witjes, A. Stenzl, P. Jichlinski, D. Jocham, Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: A meta-analysis of detection and recurrence based on raw data. Eur. Urol. 64, 846-854 (2013).
-
(2013)
Eur. Urol.
, vol.64
, pp. 846-854
-
-
Burger, M.1
Grossman, H.B.2
Droller, M.3
Schmidbauer, J.4
Hermann, G.5
Drəgoescu, O.6
Ray, E.7
Fradet, Y.8
Karl, A.9
Burgués, J.P.10
Witjes, J.A.11
Stenzl, A.12
Jichlinski, P.13
Jocham, D.14
-
25
-
-
84908605864
-
-
National Library of Medicine, Bethesda, MD, cited 27 August 2014
-
Stanford University. Phase I trial of Hu5F9-G4. In: ClinicalTrials.gov [Internet] (National Library of Medicine, Bethesda, MD, 2000) [cited 27 August 2014]. Available at http://www.clinicaltrials. gov/ct2/show/NCT02216409?term=sikic&rank=2 NLM Identifier: NCT02216409.
-
(2000)
Phase i Trial of Hu5F9-G4
-
-
Stanford University1
-
26
-
-
84872735928
-
Nanotoxicity assessment of quantum dots: From cellular to primate studies
-
K. T. Yong, W. C. Law, R. Hu, L. Ye, L. Liu, M. T. Swihart, P. N. Prasad, Nanotoxicity assessment of quantum dots: From cellular to primate studies. Chem. Soc. Rev. 42, 1236-1250 (2013).
-
(2013)
Chem. Soc. Rev.
, vol.42
, pp. 1236-1250
-
-
Yong, K.T.1
Law, W.C.2
Hu, R.3
Ye, L.4
Liu, L.5
Swihart, M.T.6
Prasad, P.N.7
-
27
-
-
84860190466
-
A molecular imaging primer: Modalities, imaging agents, and applications
-
M. L. James, S. S. Gambhir, A molecular imaging primer: Modalities, imaging agents, and applications. Physiol. Rev. 92, 897-965 (2012).
-
(2012)
Physiol. Rev.
, vol.92
, pp. 897-965
-
-
James, M.L.1
Gambhir, S.S.2
-
28
-
-
84863692660
-
A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots
-
L. Ye, K. T. Yong, L. Liu, I. Roy, R. Hu, J. Zhu, H. Cai, W. C. Law, J. Liu, K. Wang, J. Liu, Y. Liu, Y. Hu, X. Zhang, M. T. Swihart, P. N. Prasad, A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots. Nat. Nanotechnol. 7, 453-458 (2012).
-
(2012)
Nat. Nanotechnol.
, vol.7
, pp. 453-458
-
-
Ye, L.1
Yong, K.T.2
Liu, L.3
Roy, I.4
Hu, R.5
Zhu, J.6
Cai, H.7
Law, W.C.8
Liu, J.9
Wang, K.10
Liu, J.11
Liu, Y.12
Hu, Y.13
Zhang, X.14
Swihart, M.T.15
Prasad, P.N.16
-
29
-
-
84908576857
-
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
-
E. Philips, O. Penate-Medina, P. B. Zanzonico, R. D. Carvajal, P. Mohan, Y. Ye, J. Humm, M. Gönen, H. Kalaigian, H. Schöder, H. W. Strauss, S. M. Larson, U. Wiesner, M. S. Bradbury, Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci. Transl. Med. 6, 260ra149 (2014).
-
(2014)
Sci. Transl. Med.
, vol.6
, pp. 260ra149
-
-
Philips, E.1
Penate-Medina, O.2
Zanzonico, P.B.3
Carvajal, R.D.4
Mohan, P.5
Ye, Y.6
Humm, J.7
Gönen, M.8
Kalaigian, H.9
Schöder, H.10
Strauss, H.W.11
Larson, S.M.12
Wiesner, U.13
Bradbury, M.S.14
-
32
-
-
70349644860
-
Intravesical α-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice
-
B. Pfost, C. Seidl, M. Autenrieth, D. Saur, F. Bruchertseifer, A. Morgenstern, M. Schwaiger, R. Senekowitsch-Schmidtke, Intravesical α-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice. J. Nucl. Med. 50, 1700-1708 (2009).
-
(2009)
J. Nucl. Med.
, vol.50
, pp. 1700-1708
-
-
Pfost, B.1
Seidl, C.2
Autenrieth, M.3
Saur, D.4
Bruchertseifer, F.5
Morgenstern, A.6
Schwaiger, M.7
Senekowitsch-Schmidtke, R.8
-
33
-
-
84863591835
-
Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors
-
J. Carlsson, Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors. Tumour Biol. 33, 653-659 (2012).
-
(2012)
Tumour Biol.
, vol.33
, pp. 653-659
-
-
Carlsson, J.1
-
34
-
-
77956187731
-
An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors
-
E. J. Lepin, J. V. Leyton, Y. Zhou, T. Olafsen, F. B. Salazar, K. E. McCabe, S. Hahm, J. D. Marks, R. E. Reiter, A. M. Wu, An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors. Eur. J. Nucl. Med. Mol. Imaging 37, 1529-1538 (2010).
-
(2010)
Eur. J. Nucl. Med. Mol. Imaging
, vol.37
, pp. 1529-1538
-
-
Lepin, E.J.1
Leyton, J.V.2
Zhou, Y.3
Olafsen, T.4
Salazar, F.B.5
McCabe, K.E.6
Hahm, S.7
Marks, J.D.8
Reiter, R.E.9
Wu, A.M.10
-
35
-
-
70350538862
-
Immunohistochemical expression of prostate stem cell antigen in cystoprostatectomies with incidental prostate cancer
-
R. Mazzucchelli, F. Barbisan, A. Santinelli, A. Lopez-Beltran, L. Cheng, M. Scarpelli, R. Montironi, Immunohistochemical expression of prostate stem cell antigen in cystoprostatectomies with incidental prostate cancer. Int. J. Immunopathol. Pharmacol. 22, 755-762 (2009).
-
(2009)
Int. J. Immunopathol. Pharmacol.
, vol.22
, pp. 755-762
-
-
Mazzucchelli, R.1
Barbisan, F.2
Santinelli, A.3
Lopez-Beltran, A.4
Cheng, L.5
Scarpelli, M.6
Montironi, R.7
-
36
-
-
0035875053
-
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
-
N. Amara, G. S. Palapattu, M. Schrage, Z. Gu, G. V. Thomas, F. Dorey, J. Said, R. E. Reiter, Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res. 61, 4660-4665 (2001).
-
(2001)
Cancer Res.
, vol.61
, pp. 4660-4665
-
-
Amara, N.1
Palapattu, G.S.2
Schrage, M.3
Gu, Z.4
Thomas, G.V.5
Dorey, F.6
Said, J.7
Reiter, R.E.8
-
37
-
-
84904479838
-
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
-
S. Rebouissou, I. Bernard-Pierrot, A. De Reyniès, M. L. Lepage, C. Krucker, E. Chapeaublanc, A. Hérault, A. Kamoun, A. Caillault, E. Letouzé, N. Elarouci, Y. Neuzillet, Y. Denoux, V. Molinié, D. Vordos, A. Laplanche, P. Maillé, P. Soyeux, K. Ofualuka, F. Reyal, A. Biton, M. Sibony, X. Paoletti, J. Southgate, S. Benhamou, T. Lebret, Y. Allory, F. Radvanyi, EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype. Sci. Transl. Med. 6, 244ra91 (2014).
-
(2014)
Sci. Transl. Med.
, vol.6
, pp. 244ra91
-
-
Rebouissou, S.1
Bernard-Pierrot, I.2
De Reyniès, A.3
Lepage, M.L.4
Krucker, C.5
Chapeaublanc, E.6
Hérault, A.7
Kamoun, A.8
Caillault, A.9
Letouzé, E.10
Elarouci, N.11
Neuzillet, Y.12
Denoux, Y.13
Molinié, V.14
Vordos, D.15
Laplanche, A.16
Maillé, P.17
Soyeux, P.18
Ofualuka, K.19
Reyal, F.20
Biton, A.21
Sibony, M.22
Paoletti, X.23
Southgate, J.24
Benhamou, S.25
Lebret, T.26
Allory, Y.27
Radvanyi, F.28
more..
-
38
-
-
79960696534
-
Epidermal growth factor receptor expression in urinary bladder cancer
-
D. S. Naik, S. Sharma, A. Ray, S. Hedau, Epidermal growth factor receptor expression in urinary bladder cancer. Indian J. Urol. 27, 208-214 (2011).
-
(2011)
Indian J. Urol.
, vol.27
, pp. 208-214
-
-
Naik, D.S.1
Sharma, S.2
Ray, A.3
Hedau, S.4
-
39
-
-
0034782994
-
Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder
-
N. H. Chow, S. H. Chan, T. S. Tzai, C. L. Ho, H. S. Liu, Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder. Clin. Cancer Res. 7, 1957-1962 (2001).
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 1957-1962
-
-
Chow, N.H.1
Chan, S.H.2
Tzai, T.S.3
Ho, C.L.4
Liu, H.S.5
|